Intensified chemoimmunotherapy regimens are often used in young patients with double hit and triple hit lymphoma (DHL/THL) despite no survival benefit compared to R-CHOP. Favorable retrospective reports on the application of CODOX-M/IVAC-R are subject to selection bias as only young fit patients can tolerate this treatment. We conducted a retrospective analysis to investigate outcome ... https://www.jmannino.com/top-sale-Elf-Smiling-is-my-Favorite-Apple-AirPods-2-Skin-p16001-great-offer/